Synaptogenix Statistics
Share Statistics
Synaptogenix has 1.36M shares outstanding. The number of shares has increased by -93.55% in one year.
| Shares Outstanding | 1.36M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 6.57% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 1.33M |
| Failed to Deliver (FTD) Shares | 2.13K |
| FTD / Avg. Volume | 9.98% |
Short Selling Information
The latest short interest is 5.46K, so 0.4% of the outstanding shares have been sold short.
| Short Interest | 5.46K |
| Short % of Shares Out | 0.4% |
| Short % of Float | 0.41% |
| Short Ratio (days to cover) | 0.17 |
Valuation Ratios
The PE ratio is -0.52 and the forward PE ratio is -0.33.
| PE Ratio | -0.52 |
| Forward PE | -0.33 |
| PS Ratio | 0 |
| Forward PS | null |
| PB Ratio | 0.13 |
| P/FCF Ratio | -0.61 |
| PEG Ratio | n/a |
Enterprise Valuation
Synaptogenix Inc. has an Enterprise Value (EV) of -.
| EV / Earnings | null |
| EV / Sales | null |
| EV / EBITDA | null |
| EV / EBIT | null |
| EV / FCF | null |
Financial Position
The company has a current ratio of 7.14, with a Debt / Equity ratio of 0.
| Current Ratio | 7.14 |
| Quick Ratio | 7.14 |
| Debt / Equity | 0 |
| Total Debt / Capitalization | 0 |
| Cash Flow / Debt | 0 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is -0.25% and return on capital (ROIC) is -34.15%.
| Return on Equity (ROE) | -0.25% |
| Return on Assets (ROA) | -0.19% |
| Return on Capital (ROIC) | -34.15% |
| Revenue Per Employee | 0 |
| Profits Per Employee | -1.21M |
| Employee Count | 5 |
| Asset Turnover | 0 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -60.73% in the last 52 weeks. The beta is 1.43, so Synaptogenix 's price volatility has been higher than the market average.
| Beta | 1.43 |
| 52-Week Price Change | -60.73% |
| 50-Day Moving Average | 2.94 |
| 200-Day Moving Average | 3.9 |
| Relative Strength Index (RSI) | 43.57 |
| Average Volume (20 Days) | 21.35K |
Income Statement
In the last 12 months, Synaptogenix had revenue of $0 and earned -$6.04M in profits. Earnings per share was $-29.56.
| Revenue | 0 |
| Gross Profit | -6.35K |
| Operating Income | -8.31M |
| Net Income | -6.04M |
| EBITDA | -8.31M |
| EBIT | - |
| Earnings Per Share (EPS) | -29.56 |
Balance Sheet
The company has $28.66M in cash and $0 in debt, giving a net cash position of $28.66M.
| Cash & Cash Equivalents | 28.66M |
| Total Debt | 0 |
| Net Cash | 28.66M |
| Retained Earnings | -33.61M |
| Total Assets | 22.83M |
| Working Capital | 21.94M |
Cash Flow
In the last 12 months, operating cash flow was -$5.17M and capital expenditures -$2.71K, giving a free cash flow of -$5.18M.
| Operating Cash Flow | -5.17M |
| Capital Expenditures | -2.71K |
| Free Cash Flow | -5.18M |
| FCF Per Share | -11.11 |
Margins
Gross margin is 0%, with operating and profit margins of 0% and 0%.
| Gross Margin | 0% |
| Operating Margin | 0% |
| Pretax Margin | 0% |
| Profit Margin | 0% |
| EBITDA Margin | n/a% |
| EBIT Margin | n/a% |
| FCF Margin | n/a% |
Dividends & Yields
SNPX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -1098.88% |
| FCF Yield | -141.94% |
Analyst Forecast
The average price target for SNPX is $14, which is 420.4% higher than the current price. The consensus rating is "Buy".
| Price Target | $14 |
| Price Target Difference | 420.4% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
Stock Splits
The last stock split was on Apr 5, 2024. It was a backward split with a ratio of 1:25.
| Last Split Date | Apr 5, 2024 |
| Split Type | backward |
| Split Ratio | 1:25 |
Scores
| Altman Z-Score | -2.15 |
| Piotroski F-Score | 4 |